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Streptomyces erythraeus trypsin (SET) is a serine protease that is secreted extracellularly by S. eryth-
raeus. We investigated the inhibitory effect of a1-antitrypsin on the catalytic activity of SET. Intrigu-
ingly, we found that SET is not inhibited by a1-antitrypsin. Our investigations into the molecular
mechanism underlying this observation revealed that SET hydrolyzes the Met–Ser bond in the reac-
tion center loop of a1-antitrypsin. However, SET somehow avoids entrapment by a1-antitrypsin. We
also conﬁrmed that a1-antitrypsin loses its inhibitory activity after incubation with SET. Thus, our
study demonstrates that SET is not only resistant to a1-antitrypsin but also inactivates a1-antitryp-
sin.
Structured summary of protein interactions:
BT cleaves alpha1 antitrypsin by protease assay (View interaction)
alpha1 antitrypsin and BT bind by comigration in non denaturing gel electrophoresis (View interaction)
SET cleaves alpha1 antitrypsin by protease assay (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
A serine protease, Streptomyces erythraeus trypsin (SET), was
ﬁrst isolated by Yoshida and coworkers four decades ago from
the culture broth of S. erythraeus [1]. SET speciﬁcally hydrolyzes
both lysyl and arginyl peptide bonds using a catalytic mechanism
that is essentially the same as that of trypsins from mammalian
sources [2,3]. As expected, SET is inhibited by substrate-analogue
inhibitors, tosyl-Lys-CH2Cl and tosyl-Arg-CH2Cl [4], and by a Ka-
zal-type trypsin inhibitor, ovomucoid [5,6]. The mature SET con-
sists of 227 amino acid residues, with molecular weight of
22.3 kDa. SET shares 33% amino acid sequence identity with bovine
trypsin (BT) [2] and folds to essentially the same tertiary structurechemical Societies. Published by E
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r Research Institute, Clevelandas the mammalian enzyme [7]. However, there are two notable dif-
ferences between SET and the mammalian trypsins. Unlike the
mammalian protein, SET is resistant to autolysis due to the absence
of an arginine or lysine residue in the so-called ‘‘autolysis loop’’
[2,8,9]. Another unique feature of SET is that the catalytic activity
level (Km/kcat) for Na-benzoyl-L-arginine-p-nitroanilide is more
than one order of magnitude higher than that of BT [1,9].
We suspected that the bacterial protease SET would not be
inhibited by a serum serine protease inhibitor, such as a1-antitryp-
sin, because SET is not of mammalian origin. Therefore, we tested
whether a1-antitrypsin inhibits SET. a1-Antitrypsin is a 52-kDa se-
creted glycoprotein of the serpin (serine protease inhibitor) protein
superfamily [10]. Its major function is the inhibition of neutrophil
elastase [11], but it also inhibits other proteases, including trypsin.
a1-Antitrypsin has a reactive center loop that functions as ‘bait’ for
a target protease. Following the formation of a Michaelis–Menten
complex and the cleavage of the Met358–Ser359 bond in the reac-
tive center loop, a1-antitrypsin undergoes an extensive conforma-
tional rearrangement that traps the protease before completion of
its catalytic cycle at the acylenzyme intermediate stage [12,13]. Be-
cause the acylenzyme intermediate is hydrolyzed extremely slowly
[13], the inhibition of the trapped protease is virtually irreversible.
We studied the inhibitory effect of a1-antitrypsin on the cata-
lytic activity of SET and the interaction between SET and a1-anti-
trypsin. We report here that SET does hydrolyze the Met–Serlsevier B.V. All rights reserved.
Fig. 1. Inhibition of SET by a1-antitrypsin and soybean trypsin inhibitor. (a) SET
(0.2 lM) or BT (0.2 lM) was incubated with a1-antitrypsin (5 lM) or soybean
trypsin inhibitor (5 lM) at 25 C for 10 min, and residual catalytic activity was
determined. Column 1: no inhibitor; column 2: a1-antitrypsin; and column 3:
soybean trypsin inhibitor. (b) SET (0.2 lM) was incubated with a1-antitrypsin
(5 lM) at 25 C for 0, 5, and 17 h, and residual catalytic activity was determined.
The values and error bars in the ﬁgure represent the means ± standard deviations
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ited by a1-antitrypsin. The possible molecular mechanisms under-
lying this phenomenon are discussed.
2. Materials and methods
2.1. Materials
Na-benzoyl-L-arginine-p-nitroanilide (Bz-Arg-pNA) was pur-
chased from Bachem Americas (Torrance, CA), and isopropyl b-D-
thiogalactoside (IPTG) from Promega (Madison, WI). Bovine tryp-
sin, soybean trypsin inhibitor, human a1-antitrypsin, phen-
ylmethanesulfonylﬂuoride (PMSF), Na-p-tosyl-L-phenylalanine
chloromethyl ketone (TPCK) and p-aminobenzamidine-agarose
were purchased from Sigma–Aldrich (St. Louis, MO). Precast gels
for native and SDS–PAGE (sodium dodecyl sulfate–polyacrylamide
gel electrophoresis) were purchased from Bio-Rad (Hercules, CA).
All other chemicals and materials used were either reagent grade
or of the highest quality commercially available.
2.2. Preparation of recombinant SET
Cloning, expression, and puriﬁcation of SET were conducted as
described previously [9]. Brieﬂy, the pET19b-SET plasmid that en-
codes his-tagged recombinant SET protein was transformed into
Escherichia coli BL21-AI (Invitrogen, Carlsbad, CA), and protein
expression was induced by the addition of 0.2% (w/v) arabinose
and 1 mM isopropyl b-D-thiogalactoside (IPTG). After 5 h of induc-
tion, the cells were harvested by centrifugation and the cell pellet
stored at 80 C until used for protein puriﬁcation. The harvested
cells were lysed, and then the recombinant SET protein was puri-
ﬁed by sequential afﬁnity chromatography using the PrepEase His-
tidine-tagged Protein Puriﬁcation Maxi Kit-High Speciﬁcity (USB
Corporation, Cleveland, OH) and soybean trypsin inhibitor agarose
beads (Pierce, Rockford, IL).
2.3. Inhibition assay of SET
SET (0.2 lM) was pre-incubated with 5 lM of either a1-anti-
trypsin or soybean trypsin inhibitor (5 lM) in 100 mM ammonium
bicarbonate at 25 C for 10 min. After the incubation, a substrate,
Bz-Arg-pNA (1 mM), was added to the solution and proteolytic
activity was measured by monitoring the changes in absorbance
(405 nm) at 25 C with an Agilent UV/VIS spectrophotometer (San-
ta Clara, CA) [9]. The effect of the inhibitors against the activity of
BT was also measured. The concentration of SET was determined
by amino acid analysis performed at the Protein Chemistry Labora-
tory at Texas A&M University (College Station, TX) [9]. The concen-
trations of a1-antitrypsin and BT were determined from their
molar absorption coefﬁcient values at 280 nm [14].
2.4. Native and SDS–PAGE analysis
Native and SDS–PAGE were carried out using a 4–20% Mini-
PROTEAN precast gel (Bio-Rad). The native-PAGE sample buffer
contained 25 mM Tris–HCl (pH 6.8), 10% glycerol, and 0.002% bro-
mophenol blue. Protein samples were directly subjected to the na-
tive-PAGE. The SDS–PAGE sample buffer contained 25 mM Tris–
HCl (pH 6.8), 2% SDS, 2% 2-mercaptoethanol, 10% glycerol, and
0.002% bromophenol blue. Protein samples were heated at 98 C
for 10 min prior to being subjected to the SDS–PAGE. The running
buffer used for native-PAGE was 20 mM Tris–glycine (pH 8.3), and
the running buffer for SDS–PAGE was 20 mM Tris–glycine (pH 8.3)
containing 0.1% SDS. Proteins were visualized by staining with col-
loidal Coomassie Brilliant Blue G-250 (Bio-Rad).2.5. Mass spectrometry analysis
The reaction of a1-antitrypsin (40 pmol) with SET or BT
(40 pmol), in 200 lL of 100 mM ammonium bicarbonate incubated
at 25 C for 30 s, was analyzed by MALDI-TOF MS (matrix assisted
laser desorption ionization time of ﬂight mass spectrometry) with
a Perkin Elmer ProTOF 2000 mass spectrometer (Norwalk, CT). The
matrix used was 5% (w/v) a-cyano-4-hydroxycinnamic acid in 0.1%
(w/v) triﬂuoroacetic acid and 60% (v/v) acetonitrile. The matrix was
mixed with sample solution at a 4:1 ratio by volume.
2.6. Inactivation assay of a1-antitrypsin
a1-Antitrypsin (700 pmol) was incubated with 700 pmol of SET
in 100 lL of 100 mM ammonium bicarbonate at 25 C for 10 min.
After incubation, p-aminobenzamidine-agarose [15] was added to
the reaction mixture to absorb the SET protein. The mixture was
then centrifuged, and the resulting SET-free supernatant was sub-
jected to the inhibition assay with BT and SDS–PAGE analysis, as
described above.
3. Results
3.1. SET is resistant to a1-antitrypsin
The inhibitory effects of a1-antitrypsin and soybean trypsin
inhibitor on the catalytic activity of SET were investigated and
compared with inhibitory effects on BT, which was used as a posi-
tive control (Fig. 1a). The most striking ﬁnding was that SET activ-
ity was unaffected by incubation with a1-antitrypsin, whereas it
was completely lost following incubation with soybean trypsinfrom triplicate reactions.
Fig. 2. Physical interaction of SET with a1-antitrypsin. (a) SET or BT (60 pmol) was
incubated with or without a1-antitrypsin (60 pmol) in 100 lL of 100 mM ammo-
nium bicarbonate at 25 C for 10 min. The reaction was stopped by adding
100 lmol of PMSF and then subjected to native-PAGE. Lane 1: a1-antitrypsin alone;
lane 2: SET alone; lane 3: a1-antitrypsin incubated with SET; lane 4: a1-antitrypsin
alone; lane 5: BT alone; lane 6: a1-antitrypsin incubated with BT. (b) SET (20 pmol)
was incubated with varying amount of a1-antitrypsin (a1-antitrypsin/SET ratios: 0–
100) in 100 lL of 100 mM ammonium bicarbonate at 25 C for 10 min. The reaction
mixtures were then subjected to native-PAGE and SET activity assay. The results of
activity assays are expressed as means ± standard deviations from triplicate
reactions.
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sin, but not to a Kunitz-type inhibitor like soybean trypsin inhibi-
tor. As expected, BT was almost completely inhibited by either
inhibitor. To eliminate the possibility of slow inhibition of SET by
a1-antitrypsin, we also incubated SET with a1-antitrypsin for ex-
tended periods of time up to 17 h (Fig. 1b). SET retained greater
than 90% of its activity after 17 h of incubation, indicating that
SET is resistant to a1-antitrypsin.
3.2. SET does not form a covalent complex with a1-antitrypsin
It is well established that BT forms a covalent complex with a1-
antitrypsin and is thereby entrapped and inhibited [13]. Because
SET is resistant to a1-antitrypsin, it is unlikely that SET forms a
covalent complex with a1-antitrypsin. To experimentally verify
this hypothesis, SET was incubated with an equimolar amount of
a1-antitrypsin for 1 min and then the mixture was analyzed by na-
tive-PAGE. As expected, no band corresponding to a SET–a1-anti-
trypsin complex was observed (Fig. 2a, lane 3), whereas a band
corresponding to a BT–a1-antitrypsin complex was clearly visible,
as indicated in lane 6 of Fig. 2a. This result shows that an equimolar
amount of a1-antitrypsin to SET does not yield appreciable amount
of SET–a1-antitrypsin complex. Note that the band that corre-
sponds to BT was not observed in lane 5; this is because BT is a ba-
sic protein and therefore it did not migrate toward the anode under
the pH condition used for the electrophoresis (pH 8.3).
To investigate whether SET–a1-antitrypsin complex is formed
when the molar ratio of a1-antitrypsin to SET is increased, we incu-
bated SET with varying amount of a1-antitrypsin, and the reaction
mixtures were subjected to native-PAGE and SET activity assay
(Fig. 2b). A protein band that migrates slower than a1-antitrypsin
was not observed even at the a1-antitrypsin/SET ratio of 100, indi-
cating that SET does not form a covalent complex with a1-antitryp-
sin. Consistent with the conclusion, essentially no reduction of SET
band intensities and no loss of SET activities were observed up to
the a1-antitrypsin/SET ratio of 100 (Fig. 2b).
3.3. SET hydrolyzes theMet–Ser bond in the reactive center loop of a1-
antitrypsin
To explore themechanism that would explain the a1-antitrypsin
resistance of SET, a1-antitrypsin that had been incubated with SET
was analyzed by SDS–PAGE to examine proteolysis of a1-antitryp-
sin. Following incubation, two bands were visible other than the
band of SET (Fig. 3a, lane 3). The upper faint band appeared to corre-
spond to intacta1-antitrypsin, and the lower intense bandmigrated
as a protein of slightly lower molecular weight. Note that SET ran at
an apparentmolecularweight of 35 kDa, despite the fact that the ac-
tual molecular weight is 23.6 kDa. The reason for this is not clear;
however this phenomenon has been reported [2,9]. Following the
incubation of a1-antitrypsin with BT, two bands were also observed
(Fig. 3a, lane 6). The lower band appeared to have about the same
molecular weight as the lower band in lane 3; suggesting that SET
and BT hydrolyze the same site in a1-antitrypsin, which is the
Met358–Ser359 bond in the reactive center loop. The apparent
molecular weight of upper band was slightly higher than that of
a1-antitrypsin, thus presumed to be the BT–a1-antitrypsin complex.
To conﬁrm the cleavage site on a1-antitrypsin, the reaction solu-
tion of a1-antitrypsin incubated with SET or BT was subjected to
MALDI mass spectrometry. In both the reactions, a prominent peak
corresponding to a peptide of molecular weight 4132.3 Da was ob-
served (Fig. 3b), and this corresponds well to the molecular weight
of the peptide (Ser359-Lys394, theoretical mass: 4132.2) produced
by cleavage of the Met–Ser bond in the reactive center loop of a1-
antitrypsin. Thus, this result demonstrates that SET, like BT, hydro-
lyzes the Met358–Ser359 bond in the reactive center loop. The sig-nal of truncated a1-antitrypsin lacking Ser359-Lys394 was not
observed, and this was assumed to be due to the heterogeneous
nature of the glycosylations at Asn46, 83, and 247 [16].
3.4. SET inactivates a1-antitrypsin
It is known that cleavage within the reactive center loop se-
quence of a1-antitrypsin by metalloproteinases inactivates the
Fig. 3. Cleavage of a1-antitrypsin by SET. (a) SET or BT (60 pmol) was incubated
with or without human a1-antitrypsin (60 pmol) in 100 lL of 100 mM ammonium
bicarbonate at 25 C for 1 min. The reaction was stopped by adding 100 lmol of
PMSF and then subjected to SDS–PAGE. Lane 1: a1-antitrypsin alone; lane 2: SET
alone; lane 3: a1-antitrypsin incubated with SET; lane 4: a1-antitrypsin alone; lane
5: BT alone; lane 6: a1-antitrypsin incubated with BT. (b) MALDI mass spectra of a1-
antitrypsin incubated with SET (upper panel) or BT (lower panel).
Fig. 4. Inactivation of a1-antitrypsin by SET. a1-Antitrypsin (700 pmol) was
incubated with or without SET (700 pmol) in 100 lL at 25 C for 10 min. After
incubation, p-aminobenzamidine-agarose was added to the reaction mixture to
remove the SET protein. The resulting SET-treated and -untreated a1-antitrypsin
was subjected to the inhibitory assay on the catalytic activity of BT and the SDS–
PAGE analysis. (a) Inhibitory assay. Column 1: absence of a1-antitrypsin control;
column 2: SET-treated a1-antitrypsin; column 3: SET-untreated a1-antitrypsin. The
results of activity assays are expressed as means ± standard deviations from
triplicate reactions. (b) SDS–PAGE analysis. Lane 1: SET-treated a1-antitrypsin; Lane
2: SET-untreated a1-antitrypsin.
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in the reactive center loop of a1-antitrypsin by SET causes loss of
inhibition, SET-treated and -untreated a1-antitrypsin were pre-
incubated with BT and the residual tryptic activity was deter-
mined. As expected, BT activity was unaffected by SET-treated
a1-antitrypsin (Fig. 4a, column 2), but it was almost completely
inhibited by a positive control untreated a1-antitrypsin (Fig. 4a,
column 3). SDS–PAGE analysis of the SET-treated and -untreated
a1-antitrypsin conﬁrmed that the SET-treated a1-antitrypsin was
mostly cleaved form, and equal amount of SET-treated and -un-
treated a1-antitrypsin were subjected to the inhibitory assay(Fig. 4a). Thus, these results are consistent with the inactivation
of a1-antitrypsin by hydrolysis of the Met358–Ser359 bond in
the reactive center loop by SET.
4. Discussion
In this study, we have shown that SET is resistant to enzymatic
inhibition by a1-antitrypsin. To our knowledge, the only other
trypsin that has been shown to be resistant to a1-antitrypsin is
mesotrypsin [20]. However, the molecular mechanisms of a1-anti-
trypsin resistance of mesotrypsin and SET are clearly different.
Mesotrypsin does not recognize the Met358–Ser359 bond in the
reactive center loop, and therefore, the enzyme is not inhibited.
In contrast to mesotrypsin, we found that SET recognizes and
cleaves the Met358–Ser359 bond in the reactive center loop. How-
ever, SET is not subsequently trapped by the cleaved inhibitor.
Serpins are thought to be suicide substrate inhibitors of serine
proteases. However, some exceptions have been found in which
serpins become substrates of serine proteases. For example, C1
inhibitor is a good inhibitor of a-kallikrein at 38 C, however it be-
comes mostly the substrate of a-kallikrein at 4 C [21]. Other stud-
ies have also found that some of the serpin variants that have a
mutation within the reactive center loop react with proteases prin-
cipally as substrates [22–24]. Fig. 5 shows the inhibitory and sub-
strate pathways for the reaction between a serpin and protease.
Fig. 5. Reaction scheme between a serine protease and serpin. E is the serine
protease, I is the serpin, EI is a noncovalent enzyme–inhibitor complex (Michaelis–
Menten complex), [EI0] is an acylenzyme, I⁄ is a reactive site cleaved serpin, and E–I⁄
is a stable and irreversible acylenzyme complex between E and I⁄. kdiss is a rate
constant for the dissociation of [EI0], and kstab is a rate constant for the formation of
stable and irreversible complex E–I⁄.
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workers [21]. According to the reaction scheme, the protease (E)
and serpin (I) ﬁrst associate to form a noncovalent Michaelis–Men-
ten complex (EI), which is followed by the cleavage of a scissile
peptide bond in the reactive center loop of the inhibitor, and sub-
sequent formation of acylenzyme (EI0). The acylenzyme (EI0) can go
through extensive conformational rearrangement that leads to the
formation of a stable and irreversible acylenzyme complex (E–I⁄)
with a rate constant of kstab, or it can dissociate into a free enzyme
(E) and reactive site cleaved serpin (I⁄) with a rate constant of kdiss
before the conformational rearrangement occurs. According to this
reaction scheme, the interaction of SET with a1-antitrypsin appears
to be an extreme example in which the kdiss is much greater than
kstab. That is, the acylenzyme (EI0) partitions entirely toward sub-
strate. Further studies will be needed to uncover how SET escapes
the cleverly placed trap of a1-antitrypsin. The present study lays
the foundation for future studies.
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